NASDAQ:NXGL NEXGEL (NXGL) Stock Price, News & Analysis $2.66 +0.04 (+1.53%) Closing price 03:59 PM EasternExtended Trading$2.76 +0.09 (+3.57%) As of 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About NEXGEL Stock (NASDAQ:NXGL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NEXGEL alerts:Sign Up Key Stats Today's Range$2.54▼$2.7750-Day Range$2.52▼$3.1652-Week Range$1.84▼$5.10Volume10,025 shsAverage Volume66,515 shsMarket Capitalization$20.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.Read More… NEXGEL Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreNXGL MarketRank™: NEXGEL scored higher than 27% of companies evaluated by MarketBeat, and ranked 883rd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for NEXGEL. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of NEXGEL is -4.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NEXGEL is -4.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNEXGEL has a P/B Ratio of 2.96. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about NEXGEL's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.64% of the float of NEXGEL has been sold short.Short Interest Ratio / Days to CoverNEXGEL has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NEXGEL has recently decreased by 34.93%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNEXGEL does not currently pay a dividend.Dividend GrowthNEXGEL does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.64% of the float of NEXGEL has been sold short.Short Interest Ratio / Days to CoverNEXGEL has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NEXGEL has recently decreased by 34.93%, indicating that investor sentiment is improving significantly. News and Social Media2.5 / 5News SentimentN/A News SentimentNEXGEL has a news sentiment score of 1.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.83 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for NEXGEL this week, compared to 1 article on an average week. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, NEXGEL insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $65,490.00 in company stock.Percentage Held by Insiders24.86% of the stock of NEXGEL is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 2.21% of the stock of NEXGEL is held by institutions.Read more about NEXGEL's insider trading history. Receive NXGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NEXGEL and its competitors with MarketBeat's FREE daily newsletter. Email Address NXGL Stock News HeadlinesAdam R. Levy Sells 4,000 Shares of NEXGEL, Inc. (NASDAQ:NXGL) StockApril 3, 2025 | insidertrades.comNEXGEL CEO Adam Levy to Present at Planet MicroCap Showcase 2025April 9, 2025 | msn.comBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.May 2, 2025 | Crypto 101 Media (Ad)NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24thApril 7, 2025 | markets.businessinsider.comNEXGEL Reports Record-Breaking 2024 Financial PerformanceMarch 27, 2025 | msn.comNEXGEL, Inc. (NASDAQ:NXGL) Q4 2024 Earnings Call TranscriptMarch 26, 2025 | insidermonkey.comEarnings call transcript: Nexgel Q4 2024 sees revenue surge, stock jumpsMarch 26, 2025 | investing.comNEXGEL, Inc. Reports Record Q4 and Full Year 2024 Revenue Growth of 181% and 112% Respectively, Forecasts $13 Million in Revenue for 2025March 26, 2025 | nasdaq.comSee More Headlines NXGL Stock Analysis - Frequently Asked Questions How have NXGL shares performed this year? NEXGEL's stock was trading at $4.46 at the beginning of 2025. Since then, NXGL stock has decreased by 40.4% and is now trading at $2.66. View the best growth stocks for 2025 here. How were NEXGEL's earnings last quarter? NEXGEL, Inc. (NASDAQ:NXGL) released its quarterly earnings data on Monday, March, 24th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.02. The business had revenue of $3.04 million for the quarter, compared to the consensus estimate of $2.99 million. NEXGEL had a negative trailing twelve-month return on equity of 71.19% and a negative net margin of 52.60%. Read the conference call transcript. When did NEXGEL IPO? NEXGEL (NXGL) raised $14 million in an IPO on Wednesday, December 22nd 2021. The company issued 2,100,000 shares at $6.83 per share. Maxim Group LLC served as the underwriter for the IPO. How do I buy shares of NEXGEL? Shares of NXGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NEXGEL own? Based on aggregate information from My MarketBeat watchlists, some other companies that NEXGEL investors own include Lexicon Pharmaceuticals (LXRX), Aditxt (ADTX), Helius Medical Technologies (HSDT), Onconova Therapeutics (ONTX), EchoStar (SATS), American Battery Technology (ABML) and Aumann (AAG). Company Calendar Last Earnings3/24/2025Today5/02/2025Next Earnings (Estimated)5/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:NXGL CIK1468929 Webnexgel.com Phone215-702-8550FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,160,000.00 Net Margins-52.60% Pretax Margin-56.85% Return on Equity-71.19% Return on Assets-34.79% Debt Debt-to-Equity Ratio0.19 Current Ratio1.51 Quick Ratio0.93 Sales & Book Value Annual Sales$8.69 million Price / Sales2.33 Cash FlowN/A Price / Cash FlowN/A Book Value$0.90 per share Price / Book2.93Miscellaneous Outstanding Shares7,654,000Free Float5,103,000Market Cap$20.21 million OptionableNot Optionable Beta0.63 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:NXGL) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.